Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chengdu Keen Biological Technology Co., Ltd. is a specialized biotechnology company headquartered in Chengdu, China, dedicated to the research, development, and production of advanced diagnostic reagents for animal health. Founded in 2011, the company has established itself as a leader in the Chinese veterinary diagnostics market, particularly focusing on the swine and poultry industries. Its comprehensive product portfolio includes high-sensitivity ELISA kits and PCR-based detection systems for major livestock diseases such as Porcine Reproductive and Respiratory Syndrome (PRRS), Foot-and-Mouth Disease (FMD), and African Swine Fever (ASF). Chengdu Keen operates from a modern manufacturing facility in the Wenjiang District and is recognized as a national high-tech enterprise. The company's solutions are widely utilized by veterinary authorities, research institutes, and large-scale farming enterprises to ensure effective disease surveillance and biosecurity.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chengdu Keen Biological Technology.